Presentation TCT 2017 Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis Presenter: Olaf Wendler October 30, 2017 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2017 Aortic Valve Up Next Presentation TCT 2017 Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients Presenter: Michael J. Reardon October 30, 2017 More slides + Presentation TCT 2017 Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients Presenter: Thomas Walther October 30, 2017 Presentation TCT 2017 The UK All-comer TAVI Study Presenter: Neil E. Moat October 30, 2017 We Recommend
Presentation TCT 2017 Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients Presenter: Michael J. Reardon October 30, 2017
Presentation TCT 2017 Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients Presenter: Thomas Walther October 30, 2017